Govt aid will help vaccine production, says Poonawalla

In the first week of April, Poonawalla had sought Rs 3,000 crore from the government to scale up production from 70 million doses a month to 100 million doses a month by June-July. Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday thanked Prime Minister Narendra Modi and Finance Minister N Sitharaman for the … Read more

Covid-19 vaccine update: What we know about Covovax and Serum Institute’s bridging study

For Covovax, SII will be testing the safety by using 1,600 participants in 19 sites. Recently, Adar Poonawalla, CEO of Serum Institute of India (SII) said that the company will soon be working on the bridging study of Covovax vaccine and stockpiling its doses from April this year. It is to note that Covovax is … Read more

Covid-19 India update: Bottlenecks in raw materials supply unlikely to impact vaccine production, says Serum Institute

Serum Institute is manufacturing Oxford-AstraZeneca’s vaccine under the brand name Covishield. Coronavirus vaccine in India: The bottlenecks that are present in the supply of some raw materials required for the production of COVID-19 vaccines are unlikely to impact the production of doses at the Pune-based Serum Institute of India in the immediate future, according to … Read more

COVID vaccine: We have not got a pre-mature approval, says Bharat Biotech’s Dr Krishna Ella

COVID vaccine: To other question on the amount of stock of vaccines already made and ready, he said, the company has a stockpile of 20 million doses and has plans to ramp up production to 700 million doses from four plants so supply should not be a problem. (Representational photo/Reuters/File Photo) At 5 pm on … Read more

Covaxin Covid-19 vaccine update: Bharat Biotech hits out at critics, says carried out ‘200% honest’ trials

Bharat Biotech coronavirus vaccine Covaxin update: A medic fills a syringe with COVAXIN, COVID-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad. (Reuters/File Photo) Bharat Biotech Covid-19 vaccine Covaxin update: Bharat Biotech’s chairman Krishna Ella hit out at critics on Monday  saying … Read more

Serum Institute of India to make 300 million vaccine doses by July

SII will be manufacturing around 60 million doses a month from the two plants in Pune. Serum Institute of India (SII), the world’s largest vaccine manufacturer, will be ready with 300 million doses of the Covishield Oxford-AstraZeneca Covid-19 vaccine by July 2021. Adar Poonawalla, COO, SII, said they have a stockpile of 40-50 million doses … Read more

Covid-19 vaccine: Serum’s Adar Poonawalla says SII ready with stockpile of 40-50 million Covishield doses!

COVID-19 Coronavirus Vaccine: As per the production targets, Adar Poonawalla said SII will be producing around 300 million doses of Covishield by July 2021.  (Reuters image/ Representational Photo) Covid-19 vaccination drive: Adar Poonawalla, chief executive officer of vaccine-maker Serum Institute of India (SII), said on Monday that his firm was ready with a stockpile of … Read more

Centre may buy over 300 million Covishield doses by July 2021: Adar Poonawalla

Adar Poonawalla also said that SII will soon apply for emergency use authorization of Covishield. (Photo source: ANI) Hours after Prime Minister Narendra Modi visited Pune to review the preparedness of Covishield vaccine, Serum Institute of India (SII) CEO Adar Poonawalla said that indication is that the Centre may purchase around 300-400 million doses by … Read more

Coronavirus vaccine update: Results show Oxford University-AstraZeneca COVID-19 vaccine can be 90% effective

A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (AP photo/FILE) The University of Oxford and Britain’s AstraZeneca announced on Monday that the Covid-19 … Read more

Will India have Rs 80,000 crore for Covid-19 vaccine, asks Serum’s Poonawalla

Poonawalla put out a tweet on Saturday, saying this is the amount the Indian government would need to buy and distribute the vaccine to everyone in the country. The government of India would need Rs 80,000 crore for vaccinating the entire population against the Covid-19 virus. This cost was put out by Adar Poonawalla, the … Read more